← Back to catalogue

Triglycerides Reagent

FDA UDI

Class I (US FDA UDI)

by Clinical Diagnostic Solutions, Inc.

Identity

Trade Name
Triglycerides Reagent FDA UDI
Generic Name
Triglyceride IVD, reagent FDA UDI
Device Name
For the in vitro quantitative determination of Triglycerides in serum or plasma. Triglycerides determinations are of interest in the diagnosis and treatment of atherosclerosis, poorly controlled diabetes mellitus, nephrosis, liver disease, or other diseases involving lipid metabolism. FDA UDI
Model / Reference
500mL FDA UDI
Description
For the in vitro quantitative determination of Triglycerides in serum or plasma. Triglycerides determinations are of interest in the diagnosis and treatment of atherosclerosis, poorly controlled diabetes mellitus, nephrosis, liver disease, or other diseases involving lipid metabolism. FDA UDI

Identifiers

Catalog Number
501-417 FDA UDI
Primary DI / UDI-DI
00001812701208 FDA UDI
FDA Product Code
CDT FDA UDI
GMDN Term
Triglyceride IVD, reagent FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1705 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Triglycerides Reagent by Clinical Diagnostic Solutions, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 3aecc73b-3d4a-42ab-bbf0-2b421a6ea188 37 fields · synced May 30, 2026